Spots Global Cancer Trial Database for vidaza (azacitidine)
Every month we try and update this database with for vidaza (azacitidine) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Study Assessing tOTX015 in Combination With Azacitidine (AZA) or AZA Single Agent in Patients With Newly-diagnosed Acute Myeloid Leukemia (AML) Not Candidate for Standard Intensive Induction Therapy (SIIT) | NCT02303782 | Acute Myeloid L... | OTX015 Vidaza (azaciti... | 18 Years - | Oncoethix GmbH, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
